[go: up one dir, main page]

AU2003257587A1 - Method of evaluating degree of canceration of human-origin specimen - Google Patents

Method of evaluating degree of canceration of human-origin specimen

Info

Publication number
AU2003257587A1
AU2003257587A1 AU2003257587A AU2003257587A AU2003257587A1 AU 2003257587 A1 AU2003257587 A1 AU 2003257587A1 AU 2003257587 A AU2003257587 A AU 2003257587A AU 2003257587 A AU2003257587 A AU 2003257587A AU 2003257587 A1 AU2003257587 A1 AU 2003257587A1
Authority
AU
Australia
Prior art keywords
canceration
human
evaluating degree
specimen
origin specimen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003257587A
Other languages
English (en)
Other versions
AU2003257587A8 (en
Inventor
Kazuaki Miyamoto
Toshio Takada
Toshikazu Ushijima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
National Cancer Center Japan
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of AU2003257587A1 publication Critical patent/AU2003257587A1/en
Publication of AU2003257587A8 publication Critical patent/AU2003257587A8/xx
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57415Specifically defined cancers of breast
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003257587A 2002-08-23 2003-08-20 Method of evaluating degree of canceration of human-origin specimen Abandoned AU2003257587A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002243126 2002-08-23
JP2002-243126 2002-08-23
PCT/JP2003/010480 WO2004018668A1 (fr) 2002-08-23 2003-08-20 Procede d'evaluation du degre de cancerisation d'un prelevement d'origine humaine

Publications (2)

Publication Number Publication Date
AU2003257587A1 true AU2003257587A1 (en) 2004-03-11
AU2003257587A8 AU2003257587A8 (en) 2004-03-11

Family

ID=31944085

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003257587A Abandoned AU2003257587A1 (en) 2002-08-23 2003-08-20 Method of evaluating degree of canceration of human-origin specimen

Country Status (2)

Country Link
AU (1) AU2003257587A1 (fr)
WO (1) WO2004018668A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1373564A2 (fr) * 2000-09-01 2004-01-02 Epigenomics AG Diagnostic de maladies declarees ou de la predisposition a certaines maladies
DK1423528T3 (da) * 2000-09-01 2008-05-13 Epigenomics Ag Fremgangsmåde til bestemmelse af methyleringsgraden af bestemte cytosiner i genomisk DNA i sekvenskonteksten 5-CPG-3
US6893820B1 (en) * 2001-01-31 2005-05-17 The Ohio State University Research Foundation Detection of methylated CpG rich sequences diagnostic for malignant cells
CA2458182A1 (fr) * 2001-08-23 2003-03-06 Sumitomo Chemical Company, Limited Procede pour determiner le niveau de cancerisation d'un prelevement mammalien

Also Published As

Publication number Publication date
WO2004018668A1 (fr) 2004-03-04
AU2003257587A8 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
AU2003293027A1 (en) Probe array and method of its manufacture
EP1673499A4 (fr) Panneau de revetement interieur et procede de fabrication
IL174938A0 (en) Ceramic armour and method of construction
AU2003211625A1 (en) Method of modifying protein properties
AU2003277597A1 (en) Cleaning composition and method of cleaning therewith
AU2003299892A1 (en) Glass-ceramic material and method of making
AU2003282558A1 (en) Nanopellets and method of making nanopellets
AU2003264723A1 (en) Method of scanning an object
AU2003215185A1 (en) Method of making window unit
AU2003277596A1 (en) Method of deuterization
AU2003266656A1 (en) Cushion and method of evaluating the cushion
AU2002319633A1 (en) Method of predicting mechanical properties of decayed wood
AU2003217086A1 (en) Method of pipette calibration
GB0303936D0 (en) Method of testing
AU2003257587A1 (en) Method of evaluating degree of canceration of human-origin specimen
AU2002323945A1 (en) Method of evaluating degree of canceration of mammal-origin specimen
AU2001267834A1 (en) Method of evaluating useful cattle
AU2003264544A1 (en) Method of evaluationg canceration degree of mammal-origin specimen
AU2003234235A1 (en) Method of fingerprinting tissue samples
AU2003219628A1 (en) Method of preserving biological materials
AU2003290512A1 (en) Method of weldbonding
EP1679371B8 (fr) Procede pour evaluer le degre de cancerisation
AU2003299623A1 (en) Method of making mercaptoalkylalkyldialkoxysilanes
GB0325803D0 (en) Method of scanning
AU2002323775A1 (en) Method of evaluating biocompatibility

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase